Keyphrases
Neonatal Intensive Care Unit
100%
Serious Illness
47%
Neonatal Clinical Trials
35%
Communication Efficiency
35%
Parental Perspectives
35%
Parent Perspectives
26%
Pediatric Subspecialist
25%
SARS-CoV-2 Pandemic
23%
Cerebral Palsy
23%
Glucose-6-phosphate Dehydrogenase (G6PD)
23%
Universal Screening
23%
Neonate
23%
Severely Ill
23%
Compassion Satisfaction
21%
Compassion Fatigue
21%
Enrolment Rates
20%
Communication Skills Training
19%
Erythropoietin
17%
Intensive Care Unit Patients
16%
Physician Perspective
15%
Asphyxia
14%
High Dose
14%
Encephalopathy
14%
Enrolment Decision
14%
Goals of Care Conversations
14%
Social Workers
12%
PKHD1
11%
Retinal Hemorrhage
11%
Vaccination
11%
Operational Definition
11%
Well-being
11%
SpliceAI
11%
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
11%
Work Values
11%
Temporal Association
11%
Mixed Methods Analysis
11%
Deep-intronic
11%
Moral Distress
11%
Parental Experience
11%
Federal Regulations
11%
Neonatologist
11%
Decision to Participate
11%
Length of Stay
11%
Hospital Discharge
11%
Parental Factors
11%
Communication Skills
11%
Pediatric Care
11%
Periviable Gestational Age
11%
Child Development
11%
Extremely Preterm
11%
Medicine and Dentistry
Neonatal Intensive Care Unit
62%
Pediatrics
55%
Neonatal Infant
37%
Communication Skill
29%
Diseases
27%
Neonate
25%
Clinician
24%
Clinical Trial
23%
Spastic Diplegia
23%
Severe Acute Respiratory Syndrome Coronavirus 2
23%
Glucose 6 Phosphate Dehydrogenase
23%
Glucose-6-Phosphate Dehydrogenase Deficiency
23%
Compassion Fatigue
21%
Neonatology
19%
Burnout
18%
Cohort Analysis
16%
Drug Megadose
14%
Erythropoietin
14%
Asphyxia
14%
Brain Disease
14%
Allele
11%
Decision Making
11%
Retinal Haemorrhage
11%
Autosomal Recessive Inheritance
11%
Polycystic Kidney Disease
11%
Pandemic
11%
Brain Dysfunction
11%
Obstetrics
11%
Perinatology
11%
Counseling
11%
Gestational Age
11%
Symptomatic Treatment
8%
Demography
8%
Odds Ratio
8%
Shared Decision Making
7%
Disease
6%
Mental Health
6%
Intron
5%
Diagnosis
5%
Expression Analysis
5%
Exon
5%
Genetic Screening
5%
Whole Genome Sequencing
5%
Sanger Sequencing
5%
Stop Codon
5%
Weakness
5%
Newborn Death
5%
Prematurity
5%
In Vitro
5%
Reverse Transcription Polymerase Chain Reaction
5%
